Author: Focosi, Daniele; Franchini, Massimo
Title: IMPACT OF PATHOGEN-REDUCTION TECHNOLOGIES ON COVID19 CONVALESCENT PLASMA POTENCY Cord-id: taows7cf Document date: 2021_3_3
ID: taows7cf
Snippet: Pathogen reduction technologies (PRT) have been recommended by many regulatory authorities to minimize the residual risk of transfusion-transmitted infections associated with COVID19 convalescent plasma. While its impact on safety and its cost-effectiveness are nowadays well proven, there is theoretical concern that PRT could impact efficacy of convalescent plasma by altering concentration and/or function of the neutralizing antibodies (nAb). We review here the evidence supporting a lack of sign
Document: Pathogen reduction technologies (PRT) have been recommended by many regulatory authorities to minimize the residual risk of transfusion-transmitted infections associated with COVID19 convalescent plasma. While its impact on safety and its cost-effectiveness are nowadays well proven, there is theoretical concern that PRT could impact efficacy of convalescent plasma by altering concentration and/or function of the neutralizing antibodies (nAb). We review here the evidence supporting a lack of significant detrimental effect from PRTs on nAbs.
Search related documents:
Co phrase search for related documents- acid testing and acute infection patient: 1
- acute infection and log reduction: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date